Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters
The kidney is critical in the human body’s excretion of drugs and their metabolites. Renal transporters participate in actively secreting substances from the proximal tubular cells and reabsorbing them in the distal renal tubules. They can affect the clearance rates (CLr) of drugs and their metaboli...
| Published in: | Molecules |
|---|---|
| Main Authors: | Kexin Lin, Xiaorui Kong, Xufeng Tao, Xiaohan Zhai, Linlin Lv, Deshi Dong, Shilei Yang, Yanna Zhu |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/28/13/5252 |
Similar Items
Machine Learning Techniques Applied to the Study of Drug Transporters
by: Xiaorui Kong, et al.
Published: (2023-08-01)
by: Xiaorui Kong, et al.
Published: (2023-08-01)
Contribution and expression of renal drug transporters in renal cell carcinoma
by: Yawen Zuo, et al.
Published: (2025-02-01)
by: Yawen Zuo, et al.
Published: (2025-02-01)
Drug Transporters and Metabolizing Enzymes in Antimicrobial Drug Pharmacokinetics: Mechanisms, Drug–Drug Interactions, and Clinical Implications
by: Kaili Lin, et al.
Published: (2025-06-01)
by: Kaili Lin, et al.
Published: (2025-06-01)
Renal drug transporters and their significance in drug–drug interactions
by: Jia Yin, et al.
Published: (2016-09-01)
by: Jia Yin, et al.
Published: (2016-09-01)
Relationship between metabolic reprogramming and drug resistance in breast cancer
by: Linlin Lv, et al.
Published: (2022-08-01)
by: Linlin Lv, et al.
Published: (2022-08-01)
Entecavir interacts with influx transporters hOAT1, hCNT2, hCNT3, but not with hOCT2: the potential for renal transporter-mediated cytotoxicity and drug-drug interactions
by: František eTrejtnar, et al.
Published: (2016-01-01)
by: František eTrejtnar, et al.
Published: (2016-01-01)
Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions
by: Jie Li, et al.
Published: (2022-09-01)
by: Jie Li, et al.
Published: (2022-09-01)
Dysregulation of the mRNA Expression of Human Renal Drug Transporters by Proinflammatory Cytokines in Primary Human Proximal Tubular Epithelial Cells
by: Yik Pui Tsang, et al.
Published: (2024-02-01)
by: Yik Pui Tsang, et al.
Published: (2024-02-01)
Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions
by: Ruohui Zheng, et al.
Published: (2022-09-01)
by: Ruohui Zheng, et al.
Published: (2022-09-01)
Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
by: Yang Li, et al.
Published: (2021-09-01)
by: Yang Li, et al.
Published: (2021-09-01)
The Role of ABCB1, ABCG2, and SLC Transporters in Pharmacokinetic Parameters of Selected Drugs and Their Involvement in Drug–Drug Interactions
by: Kajetan Kiełbowski, et al.
Published: (2024-10-01)
by: Kajetan Kiełbowski, et al.
Published: (2024-10-01)
Expanding Role of Endogenous Biomarkers for Assessment of Transporter Activity in Drug Development: Current Applications and Future Horizon
by: Vikram Arya, et al.
Published: (2024-06-01)
by: Vikram Arya, et al.
Published: (2024-06-01)
Role of drug transporters in drug development: a qualitative and quantitative approach
by: Sumit Basu, et al.
Published: (2017-06-01)
by: Sumit Basu, et al.
Published: (2017-06-01)
Editorial: Drug metabolism and transport: the Frontier of personalized medicine
by: Junmin Zhang, et al.
Published: (2023-07-01)
by: Junmin Zhang, et al.
Published: (2023-07-01)
Enantioselective Drug Recognition by Drug Transporters
by: Yuichi Uwai
Published: (2018-11-01)
by: Yuichi Uwai
Published: (2018-11-01)
Interaction of ALK Inhibitors with Polyspecific Organic Cation Transporters and the Impact of Substrate-Dependent Inhibition on the Prediction of Drug–Drug Interactions
by: Yik Pui Tsang, et al.
Published: (2023-09-01)
by: Yik Pui Tsang, et al.
Published: (2023-09-01)
Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
by: Johanna Weiss, et al.
Published: (2020-09-01)
by: Johanna Weiss, et al.
Published: (2020-09-01)
Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
by: Jörg König, et al.
Published: (2011-10-01)
by: Jörg König, et al.
Published: (2011-10-01)
Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story
by: Yuki Ujihira, et al.
Published: (2025-05-01)
by: Yuki Ujihira, et al.
Published: (2025-05-01)
Metabolism and transporter based drug–drug interaction of tacrolimus with nine co-medicated injections
by: Qing Xu, et al.
Published: (2021-06-01)
by: Qing Xu, et al.
Published: (2021-06-01)
OAT3 Participates in Drug–Drug Interaction between Bentysrepinine and Entecavir through Interactions with M8—A Metabolite of Bentysrepinine—In Rats and Humans In Vitro
by: Aijie Zhang, et al.
Published: (2023-02-01)
by: Aijie Zhang, et al.
Published: (2023-02-01)
Advances in the Targeted Drug Delivery System for Renal Fibrosis
by: Zheng YY, et al.
Published: (2026-06-01)
by: Zheng YY, et al.
Published: (2026-06-01)
Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021
by: Kyeong-Ryoon Lee, et al.
Published: (2022-09-01)
by: Kyeong-Ryoon Lee, et al.
Published: (2022-09-01)
Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro
by: Johanna Weiss, et al.
Published: (2014-12-01)
by: Johanna Weiss, et al.
Published: (2014-12-01)
In Vitro Investigations into the Potential Drug Interactions of Pseudoginsenoside DQ Mediated by Cytochrome P450 and Human Drug Transporters
by: Zhuo Li, et al.
Published: (2024-05-01)
by: Zhuo Li, et al.
Published: (2024-05-01)
Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database
by: Jinming Han, et al.
Published: (2025-04-01)
by: Jinming Han, et al.
Published: (2025-04-01)
In silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens
by: Adrián César-Razquin, et al.
Published: (2018-09-01)
by: Adrián César-Razquin, et al.
Published: (2018-09-01)
Editorial: New drugs and future challenges in drug metabolism and transport
by: Maja Đanić, et al.
Published: (2026-06-01)
by: Maja Đanić, et al.
Published: (2026-06-01)
A useful tool for drug interaction evaluation: The University of Washington Metabolism and Transport Drug Interaction Database
by: Hachad Houda, et al.
Published: (2010-10-01)
by: Hachad Houda, et al.
Published: (2010-10-01)
New Immunosuppressive Drugs Used in Renal Transplantation
by: Özkan GÜNGÖR, et al.
Published: (2019-02-01)
by: Özkan GÜNGÖR, et al.
Published: (2019-02-01)
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications
by: Jingjing Yu, MD, PhD, et al.
Published: (2026-06-01)
by: Jingjing Yu, MD, PhD, et al.
Published: (2026-06-01)
Advanced Drug Delivery Systems for Renal Disorders
by: Batoul Alallam, et al.
Published: (2023-02-01)
by: Batoul Alallam, et al.
Published: (2023-02-01)
Lysosomal Drug Sequestration Mediated by ABC Transporters and Drug Resistance
by: Petr Mlejnek
Published: (2025-09-01)
by: Petr Mlejnek
Published: (2025-09-01)
Drug-related acute renal failure in hospitalised patients
by: Lujan Iavecchia, et al.
Published: (2015-11-01)
by: Lujan Iavecchia, et al.
Published: (2015-11-01)
Quantitative prediction of pharmacokinetic properties of drugs in humans: Recent advance in in vitro models to predict the impact of efflux transporters in the small intestine and blood–brain barrier
by: Yoshiki Hashimoto, et al.
Published: (2022-01-01)
by: Yoshiki Hashimoto, et al.
Published: (2022-01-01)
Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects
by: M. Rasheduzzaman Jony, et al.
Published: (2024-08-01)
by: M. Rasheduzzaman Jony, et al.
Published: (2024-08-01)
Editorial: Advanced chemical and material tools to enhance the therapeutic effect of drugs
by: Ayesha Ihsan, et al.
Published: (2023-08-01)
by: Ayesha Ihsan, et al.
Published: (2023-08-01)
CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients
by: Yilei Yang, et al.
Published: (2021-07-01)
by: Yilei Yang, et al.
Published: (2021-07-01)
Differential Preincubation Effects of Nicardipine on OATP1B1- and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1- and OATP1B3-Mediated Drug–Drug Interactions
by: Ruhul Kayesh, et al.
Published: (2023-03-01)
by: Ruhul Kayesh, et al.
Published: (2023-03-01)
Research progress on reversing tumor resistance based on the epigenetics of drug metabolizing enzymes and transporters
by: Xiao-Li ZHENG, et al.
Published: (2020-12-01)
by: Xiao-Li ZHENG, et al.
Published: (2020-12-01)
Similar Items
-
Machine Learning Techniques Applied to the Study of Drug Transporters
by: Xiaorui Kong, et al.
Published: (2023-08-01) -
Contribution and expression of renal drug transporters in renal cell carcinoma
by: Yawen Zuo, et al.
Published: (2025-02-01) -
Drug Transporters and Metabolizing Enzymes in Antimicrobial Drug Pharmacokinetics: Mechanisms, Drug–Drug Interactions, and Clinical Implications
by: Kaili Lin, et al.
Published: (2025-06-01) -
Renal drug transporters and their significance in drug–drug interactions
by: Jia Yin, et al.
Published: (2016-09-01) -
Relationship between metabolic reprogramming and drug resistance in breast cancer
by: Linlin Lv, et al.
Published: (2022-08-01)
